Abstract
Morquio syndrome, also known as Morquio-Brailsford syndrome or mucopolysaccharidosis type IV (MPS IV), is a subgroup of mucopolysaccharidosis. It is an autosomal recessive lysosomal storage disorder. Two subtypes of Morquio syndrome have been identified. In MPS IVA, a deficiency in N-acetylgalactosamine-6-sulfate sulfatase interrupts the normal metabolic pathway of degrading glycosaminoglycans. Accumulated undigested glycosaminoglycans in the tissue and bones result in complications leading to severe skeletal deformity. In MPS IVB, a deficiency in beta-galactosidase results in a milder phenotype than in MPS IVA. Morquio syndrome presents a variety of clinical manifestations in a spectrum of mild to severe. It classically has been considered a skeletal dysplasia with significant skeletal involvement. However, the extraskeletal features can also provide valuable information to guide further work-up to assess the possibility of the disorder. Although the disease involves almost all parts of the body, it most commonly affects the axial skeleton, specifically the vertebrae. The characteristic radiologic findings in MPS IV, such as paddle-shaped ribs, odontoid hypoplasia, vertebral deformity, metaphyseal and epiphyseal bone dysplasia, and steep acetabula, are encompassed in the term “dysostosis multiplex,” which is a common feature among other types of MPS and storage disorders. Myelopathy due to spinal cord compression and respiratory airway obstruction are the most critical complications related to mortality and morbidity. The variety of clinical features, as well as overlapping of radiological findings with other disorders, make diagnosis challenging, and delays in diagnosis and treatment may lead to critical complications. Timely imaging and radiologic expertise are important components for diagnosis. Gene therapies may provide robust treatment, particularly if genetic variations can be screened in utero.
Similar content being viewed by others
Data availability
There are no data available.
References
Palmucci S, Attinà G, Lanza ML et al (2013) Imaging findings of mucopolysaccharidoses: A pictorial review. Insights Imaging 4:443–459
Hendriksz CJ, Harmatz P, Beck M et al (2013) Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA. Mol Genet Metab 110:54–64
Khedhiri S, Chkioua L, Bouzidi H et al (2009) Mucopolysaccharidoses type I and IVA: Clinical features and consanguinity in Tunisia. Pathol Biol 57:392–397
Leong HY, Abdul Azize NA, Chew HB et al (2019) Clinical, biochemical and genetic profiles of patients with mucopolysaccharidosis type IVA (Morquio A syndrome) in Malaysia: The first national natural history cohort study. Orphanet J Rare Dis 14:143
Leadley RM, Lang S, Misso K et al (2014) A systematic review of the prevalence of Morquio A syndrome: challenges for study reporting in rare diseases. Orphanet J Rare Dis 9:173
Lavery C, Hendriksz C (2014) Mortality in patients with Morquio syndrome A. JIMD Rep 15:59–66
Sawamoto K, Suzuki Y, Mackenzie WG et al (2016) Current therapies for Morquio A syndrome and their clinical outcomes. Expert Opin Orphan Drugs 4:941–951
Reichert R, Campos LG, Vairo F et al (2016) Neuroimaging findings in patients with mucopolysaccharidosis: what you really need to know. Radiographics 36:1448–1462
Matalon R, Arbogast B, Justice P et al (1974) Morquio’s syndrome. Deficiency of a chondroitin sulfate N-acetylhexosamine sulfate sulfatase. Biochem Biophys Res Commun 61:759–765
Ginsberg LC, Donnelly PV, Di Ferrante DT et al (1978) N-acetylglucosamine-6-sulfate sulfatase in man: Deficiency of the enzyme in a new mucopolysaccharidosis. Pediatr Res 12:805–809
Pedrini-Mille A, Pedrini V, Ponseti IV (1974) Glycosaminoglycans of iliac crest cartilage in spondyloepiphyseal dysplasia congenita. Calcif Tissue Res 16:183–192
Arbisser AI, Donnelly KA, Scott CI et al (1977) Morquio-like syndrome with beta galactosidase deficiency and normal hexosamine sulfatase activity: mucopolysacchariodosis IVB. Am J Med Genet 1:195–205
Holzgreve W, Gröbe H, von Figura K et al (1981) Morquio syndrome: Clinical findings in 11 patients with MPS IVA and 2 patients with MPS IVB. Hum Genet 57:360–365
Krakow D, Rimoin DL (2010) The skeletal dysplasias. Genet Med 12:327–341
Mortier GR, Cohn DH, Cormier-Daire V et al (2019) Nosology and classification of genetic skeletal disorders: 2019 revision. Am J Med Genet Part A 179:2393–2419
Cormier-Daire V (2008) Spondylo-epi-metaphyseal dysplasia. Best Pract Res Clin Rheumatol 22:33–44
Lee NH, Cho SY, Maeng SH et al (2012) Clinical, radiologic, and genetic features of Korean patients with Mucopolysaccharidosis IVA. Korean J Pediatr 55:430–437
Montaño AM, Tomatsu S, Gottesman GS et al (2007) International Morquio A Registry: Clinical manifestation and natural course of Morquio A disease. J Inherit Metab Dis 30:165–174
Yasuda E, Fushimi K, Suzuki Y et al (2013) Pathogenesis of morquio A syndrome: An autopsied case reveals systemic storage disorder. Mol Genet Metab 109:301–311
Zustin J (2010) Morquio disease: The role of cartilage canals in the pathogenesis of chondrogenic dwarfism. Med Hypotheses 75:642–644
Caciotti A, Cellai L, Tonin R et al (2021) Morquio B disease: From pathophysiology towards diagnosis. Mol Genet Metab 132:180–188
Jaremko JL, Siminoski K, Firth GB et al (2015) Common normal variants of pediatric vertebral development that mimic fractures: a pictorial review from a national longitudinal bone health study. Pediatr Radiol 45:593–605
Tomatsu S, Montaño AM, Lopez P et al (2006) Determinant factors of spectrum of missense variants in mucopolysaccharidosis IVA gene. Mol Genet Metab 89:139–149
Tomatsu S, Fukuda S, Cooper A et al (1997) Fourteen novel mucopolysaccharidosis IVA producing mutations in GALNS gene. Hum Mutat 10:368–375
Peretz RH, Flora CH, Adams DJ (2020) Natural history of the oldest known females with mucopolysaccharidosis type IVA (Morquio A syndrome). Am J Med Genet Part A 182:1491–1495
Bhattacharya K, Balasubramaniam S, Choy YS et al (2014) Overcoming the barriers to diagnosis of Morquio A syndrome. Orphanet J Rare Dis 9:192
Aldenhoven M, Sakkers RJB, Boelens J et al (2009) Musculoskeletal manifestations of lysosomal storage disorders. Ann Rheum Dis 68:1659–1665
Harmatz P, Mengel KE, Giugliani R et al (2013) The Morquio A Clinical Assessment Program: Baseline results illustrating progressive, multisystemic clinical impairments in Morquio A subjects. Mol Genet Metab 109:54–61
Langer LO, Carey LS (1966) The roentgenographic features of the KS mucopolysaccharidosis of Morquio (Morquio-Brailsford’s disease). Am J Roentgenol Radium Ther Nucl Med 97:1–20
Montaño AM, Tomatsu S, Brusius A et al (2008) Growth charts for patients affected with Morquio A disease. Am J Med Genet Part A 146:1286–1295
Rush ET (2016) Atypical presentation of mucopolysaccharidosis type IVA. Mol Genet Metab Reports 8:8–12
Orii T, Kiman T, Sukegawa K et al (1971) Late onset N-acetylgalactosamine-6-sulfate sulfatase deficiency in two brothers. Connect Tissue (in Japanese) 5:72–78
Orii T, Minami R, Chiba G et al (1971) Study on Morquio syndrome 5:72–78
Tomatsu S, Mackenzie WG, Theroux MC et al (2012) Current and emerging treatments and surgical interventions for Morquio A syndrome: a review. Res Rep Endocr Disord 2012:65–77
Hecht JT, =Scott CI Jr, Smith TK, Williams JC, et al (1984) Mild manifestations of the Morquio syndrome. Am J Med Genet 18:369–371
Beck M, Glössl J, Grubisic A, Spranger J (1986) Heterogeneity of Morquio disease. Clin Genet 29:325–331
Lachman RS, Burton BK, Clarke LA et al (2014) Mucopolysaccharidosis IVA (Morquio A syndrome) and VI (Maroteaux-Lamy syndrome): Under-recognized and challenging to diagnose. Skeletal Radiol 43:359–369
Blaw ME, Langer LO (1969) Spinal cord compression in Morquio-Brailsford’s disease. J Pediatr 74:593–600
Davison JE, Kearney S, Horton J et al (2013) Intellectual and neurological functioning in Morquio syndrome (MPS IVa). J Inherit Metab Dis 36:323–328
Dhawale AA, Thacker MM, Belthur MV et al (2012) The lower extremity in morquio syndrome. J Pediatr Orthop 32:534–540
Semenza GL, Pyeritz RE (1988) Respiratory complications of mucopolysaccharide storage disorders. Medicine (Baltimore) 67:209–219
Theroux MC, Nerker T, Ditro C, Mackenzie WG (2012) Anesthetic care and perioperative complications of children with Morquio syndrome. Paediatr Anaesth 22:901–907
Bonafe L, Cormier-Daire V, Hall C et al (2015) Nosology and classification of genetic skeletal disorders: 2015 revision. Am J Med Genet Part A 167:2869–2892
Spina V, Barbuti D, Gaeta A et al (2018) The role of imaging in the skeletal involvement of mucopolysaccharidoses. Ital J Pediatr 44(Suppl 2):118
Panda A, Gamanagatti S, Jana M, Gupta AK (2014) Skeletal dysplasias: A radiographic approach and review of common non-lethal skeletal dysplasias. World J Radiol 6:808–825
Nelson J, Kinirons M (1988) Clinical findings in 12 patients with MPS IV A (Morquio’s disease): Further evidence for heterogeneity. Part II: Dental findings Clin Genet 33:121–125
Chien Y-H, Lee N-C, Chen P-W et al (2020) Newborn screening for Morquio disease and other lysosomal storage diseases: Results from the 8-plex assay for 70,000 newborns. Orphanet J Rare Dis 15:38
Kumar R, Guinto FC Jr, Madewell JE et al (1988) The vertebral body: radiographic configurations in various congenital and acquired disorders. Radiographics 8:455–485
Borlot F, Arantes PR, Quaio CR et al (2014) Mucopolysaccharidosis type IVA: Evidence of primary and secondary central nervous system involvement. Am J Med Genet Part A 164:1162–1169
Ransford AO, Crockard HA, Stevens JM, Modaghegh S (1996) Occipito-atlanto-axial fusion in Morquio-Brailsford syndrome: A ten-year experience. J Bone Jt Surg Br 78:307–313
Stevens JM, Kendall BE, Crockard HA, Ransford A (1991) The odontoid process in Morquio-Brailford’s disease. The effects of occipitocervical fusion. J Bone Joint Surg Br 73:851–858
Hughes DG, Chadderton RD, Cowie RA et al (1997) MRI of the brain and craniocervical junction in Morquio’s disease. Neuroradiology 39:381–385
Kulkarni MV, Williams JC, Yeakley JW et al (1987) Magnetic resonance imaging in the diagnosis of the cranio-cervical manifestations of the mucopolysaccharidoses. Magn Reson Imaging 5:317–323
Miao M, Wang Z, Cai H et al (2020) Hip morphology in mucopolysaccharidosis type IVA through radiograph, magnetic resonance imaging and arthrogram assessment. Int Orthop 44:1677–1683
Er MS, Abousamra O, Rogers K et al (2017) Upper cervical fusion in children with spondyloepiphyseal dysplasia congenita. J Pediatr Orthop 37:466–472
de Almeida-Barros RQ, de Medeiros PFV, de Almeida Azevedo MQ et al (2018) Evaluation of oral manifestations of patients with mucopolysaccharidosis IV and VI: clinical and imaging study. Clin Oral Investig 22:201–208
Horrigan WD, Baker DH (1961) Gargoylism: review and roentgen skull changes with description of new finding. Am J Roentgenol Radium Ther Nucl Med 86:473–477
Yabe H, Tanaka A, Chinen Y et al (2016) Hematopoietic stem cell transplantation for Morquio A syndrome. Mol Genet Metab 117:84–94
Kinirons MJ, Nelson J (1990) Dental findings in mucopolysaccharidosis type IV A (Morquio’s disease type A). Oral Surg Oral Med Oral Pathol 70:176–179
Nelson J, Broadhead D, Mossman J (1988) Clinical findings in 12 patients with MPS IV A (Morquio’s disease): Further evidence for heterogeneity. Part I: Clinical and biochemical findings. Clin Genet 33:111–120
Wang Z, Xu Y, Jiang E et al (2020) Pathophysiology of hip disorders in patients with mucopolysaccharidosis IVA. Diagnostics (Basel) 10:264
Tomatsu S, Montano AM, Oikawa H et al (2011) Mucopolysaccharidosis type IVA (Morquio A disease): clinical review and current treatment. Curr Pharm Biotechnol 12:931–945
Wood TC, Harvey K, Beck M et al (2013) Diagnosing mucopolysaccharidosis IVA. J Inherit Metab Dis 36:293–307
Tomatsu S, Sawamoto K, Shimada T et al (2015) Enzyme replacement therapy for treating mucopolysaccharidosis type IVA (Morquio A syndrome): effect and limitations. Expert Opin Orphan Drugs 3:1279–1290
Kenth JJ, Thompson G, Fullwood C et al (2019) The characterisation of pulmonary function in patients with mucopolysaccharidoses IVA: A longitudinal analysis. Mol Genet Metab Rep 20:100487
Moisan L, Iannuzzi D, Maranda B et al (2020) Clinical characteristics of patients from Quebec, Canada, with Morquio A syndrome: A longitudinal observational study. Orphanet J Rare Dis 15:270
Lee C-L, Chuang C-K, Chiu H-C et al (2022) Clinical utility of elosulfase alfa in the treatment of Morquio A syndrome. Drug Des Devel Ther 16:143–154
Acknowledgements
The authors gratefully acknowledge Professor Mehrzad Mehdizadeh, Dr. Mostafa Zoorpaikar and the Pediatric Medical Center of the University of Tehran, Iran, for providing us with a rich radiographic collection of Morquio syndrome and the images presented in this work.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical statement
As the images provided in this work formed part of an educational collection at the University of Tehran, Institutional Review Board ethics approval was waived.
Conflicts of interest
None
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Padash, S., Obaid, H., Henderson, R.D.E. et al. A pictorial review of the radiographic skeletal findings in Morquio syndrome (mucopolysaccharidosis type IV). Pediatr Radiol 53, 971–983 (2023). https://doi.org/10.1007/s00247-022-05585-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00247-022-05585-3